U4 Helpdesk Answer - Corruption risks related to investment in vaccine

20.500.12592/t5jq5k

U4 Helpdesk Answer - Corruption risks related to investment in vaccine

16 Jan 2023

Different groups of actors must collaborate to make more Vaccine inequity is one of the most harmful and information available for scrutiny, deplorable aspects of the global response to the including on the public funding and Covid-19 pandemic. [...] consortium to operate the hub.1 The hub receives support from the WHO, the Medicines Patent Pool The need for increased vaccine manufacturing and the Act-Accelerator/COVAX. [...] fall under the category of blended finance, the use The company eventually dropped the requests but of development finance to mobilise additional this led to a delay to vaccine delivery dates (Davies commercial finance for investments in low and and Furneaux 2021). [...] These risks stem from several factors including a lack of transparency around the terms of In 2016, the Ministry of Defence (MOD) won an concessional financing and the ways in which the exclusive right to procure “strategic” medical recipients of funds are selected; transaction supplies, including vaccines, for the Ministry of structures that channel resources through financial Health. [...] Vaccine manufacturers based in Africa looking to export to Corruption in Covid-19 procurement in South other countries in the region must recognise that Africa the nature of corruption in procurement will vary across markets.

Authors

Matthew Jenkins

Pages
18
Published in
Norway